Therefore, it can be concluded that, despite quercetin's favourable anti‐cancer properties, such treatment may exacerbate prostate cancer progression via upregulated VEGF‐c isoform in remaining tumour cells. The gene discussed is VEGFC; the disease is neoplasm.